Author

Teresa Ricciardi

Observed names: RICCIARDI, TERESA, Ricciardi, T., Ricciardi, Teresa, T Ricciardi, T. Ricciardi

Institutions: Institute of Biosciences and Bioresources, HAL Allergy (Netherlands), National Research Council

Observed institutions: University of Urbino, Institute of Biosciences and Bioresources, Ospedali Riuniti Marche Nord, HAL Allergy (Netherlands), National Research Council

OpenAlex ID: A5109404262

Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer

2016 · F Graziano, A Ruzzo, et al. · The Pharmacogenomics Journal · 110

Molecular approach to a patient’s tailored diagnosis of the oral allergy syndrome

2020 · Claudia Alessandri, Rosetta Ferrara, et al. · Clinical and Translational Allergy · 60

Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT

2014 · G Visani, B Guiducci, et al. · Bone Marrow Transplantation · 27

Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)

2016 · Carlo Garufi, Elisa Giacomini, et al. · Scientific Reports · 24

Pomegranate chitinase III: Identification of a new allergen and analysis of sensitization patterns to chitinases

2018 · Lisa Tuppo, Ivana Giangrieco, et al. · Molecular Immunology · 22

High-dose therapy followed by stem cell transplantation in Hodgkin’s lymphoma: past and future

2013 · Alessandro Isidori, Pier Paolo Piccaluga, et al. · Expert Review of Hematology · 19

Glucose metabolism enzymes gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer (CRC)

2015 · E. Ongaro, A. Ruzzo, et al. · Annals of Oncology · 1

Bendamustine, Etoposide, Cytarabine and Melphalan (BeEAM) Followed By Autologous Stem Cell Transplantation Produce a 3-Year Progression-Free Survival Of 75% In Heavily Pre-Treated Hodgkin and Non-Hodgkin Lymphoma

2013 · Giuseppe Visani, Pietro Maria Stefani, et al. · Blood · 1

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

2013 · Giuseppe Visani, Francesco Di Raimondo, et al. · Blood · 1

Glucose metabolism enzymes gene expression analysis and selective metabolic advantage in the progression of colorectal cancer (CRC).

2015 · Francesco Graziano, Annamaria Ruzzo, et al. · Journal of Clinical Oncology

Differente sopravvivenza tra maschi e femmine associata a polimorfismi e miRNA correlati ai clock-genes in pazienti con cancro metastatico del colon-retto

2015 · Mauro Magnani, Teresa Ricciardi, et al.

The Mutational Status Of Genes Involved In DNA Repair and Folate Pathway Predicts Overall Survival Of Patients With Low-Risk, Untreated Myelodysplastic Syndrome

2013 · Alessandro Isidori, Annamaria Ruzzo, et al. · Blood

Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for ?-thalassemia major

2013 · Giuseppe Visani, Paola Picardi, et al. · Mediterranean Journal of Hematology and Infectious Diseases

New conditioning regimens in lymphomas

2013 · G. Visani, P. Picardi, et al. · Drugs and Cell Therapies in Hematology

New conditioning regimens in lymphomas

2013 · G. Visani, P. Picardi, et al. · Drugs and Cell Therapies in Hematology

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

2011 · Giuseppe Visani, Felicetto Ferrara, et al. · Blood

Works count: 22

Citation count: 265

H-index: 6

I10-index: 6